Rare Case of MG Crisis Attributed to COVID-19 Vaccine
A very rare case of a myasthenia gravis (MG) crisis caused by the Moderna COVID-19 vaccine was described recently…
Articles by Marisa Wexler, MS
Rare 2030 Action Campaign Pushing for European Plan for Rare Diseases
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Immunovant Planning Pivotal Trial of IMVT-1401
Following a review of available clinical data, Immunovant has announced plans to resume clinical testing of the investigational medication…
Early Swallowing Difficulty Tied to Worse Outcomes
People with myasthenia gravis (MG) who have difficulty swallowing are more likely to have poor clinical outcomes, according to…
#AANAM – Fatigue Common in MG, Even for People With Milder Forms
Editor’s note: The Myasthenia Gravis News team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April…
#MDA2021 – Infection Risk Found Unaffected by Long-term Soliris Use
When used over long periods of time, Soliris (eculizumab) does not increase the risk of infections in people with…
FDA Reviewing Efgartigimod as Possible Treatment for Generalized MG
The U.S. Food and Drug Administration (FDA) is now reviewing an application from Argenx that seeks approval of …
Horizon Acquires Viela, Will Develop Inebilizumab for MG Symptoms
In a $3.05 billion deal, Horizon Therapeutics will acquire Viela Bio, the developer of inebilizumab, a potential treatment for autoimmune…
AstraZeneca Set to Acquire Alexion Pharmaceuticals in 2021
After unanimous votes by the boards of directors of both companies, AstraZeneca has announced it will acquire Alexion…
NORD Hosting ‘RareLaunch’ Workshops to Help Start Rare Disease Non-profits
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of free virtual workshops…